Signal active
Investment Firm
Overview
N/A
Highlights
Invalid date
0
23
8
undefined
Early Stage Venture, Private Equity, Late Stage Venture
N/A
Location
N/A
Contact Information
Social
N/A
Employees
N/A
Investment portfolio
23
0
8
undefined
Investments
23
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Jan 01, 2023 | Nexi Group | E-Commerce | null |
Jan 01, 2023 | Proterial | Manufacturing | null |
Jan 01, 2023 | Aveanna Healthcare | Health Care | null |
Jul 16, 2024 | Cardurion Pharmaceuticals | Biotechnology | 260.0M |
Exits
0
Funding Timeline
23
0
0
Funding Rounds
23
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Jan 01, 2023 | Private Equity Round - Nexi Group | - | 0 | - |
Jan 01, 2023 | Private Equity Round - Proterial | - | 0 | - |
Jan 01, 2023 | Post-IPO Equity - Aveanna Healthcare | - | 0 | - |
Jul 16, 2024 | Series B - Cardurion Pharmaceuticals | - | 260.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
Funding Round
Jul 16, 2024
Cardurion Pharmaceuticals raised $260000000 on 2024-07-16 in Series B
Funding Round
Jan 01, 2023
Aveanna Healthcare raised an undisclosed amount on 2023-01-01 in Post-IPO Equity
Funding Round
Jan 01, 2023
Proterial raised an undisclosed amount on 2023-01-01 in Private Equity Round
Funding Round
Jan 01, 2023
Nexi Group raised an undisclosed amount on 2023-01-01 in Private Equity Round
Funding Round
Jan 01, 2023
Arxada raised an undisclosed amount on 2023-01-01 in Private Equity Round